Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR
December 10, 2014 at 07:30 AM EST
Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) today announced that on December 9, 2014 the Company received a Paragraph IV Notice Letter ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.